Viorgon-26

Bone tissue bioregulator.

Composition: 1 ml of a sterile solution contains 0.1 ± 0.01 mg of CaCl2 and 10-13-10-14 mg of a protein-peptide complex isolated from the bone tissue of young gobies.
Physiological effect of viorgon-26: regulatory effect on the processes underlying the biosynthesis of bone tissue, in particular, on the ratio of osteoblasts and osteoclasts

Indications for use: Viorgon-26 is recommended for use in limb fractures, joint pain, arthritis and arthrosis, for the prevention of osteoporosis.

Mode of application
Viorgon can be taken by application to the mucous membrane, intranasally: by instilling into the nasal cavity, or sublingually: by ordering under the tongue. In this case, the dosage starts from 3 drops.

Viorgon can be taken orally, diluting in water at the rate of at least 8-10 drops per 100 ml of water. Drink at least 20-30 minutes before eating or 2 hours after.

A positive effect is observed from the use of 3 or more times a day. An overdose of viorgon preparations is excluded, it is allowed to take as many times a day as they will favorably affect the well-being. The addictive effect is also absent.

The interval between the various viorgons is at least 10 minutes.